🔗 Permalink

Inventor profile of:

Xinping Fu

City:

Houston, Texas

Country:

United States

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Xinping Fu

The entities that hold a legal rights for patent applications filed by inventor Fu Xinping:

THE UNIVERSITY OF HOUSTON SYSTEM 2 Houston, TX United States

Recent patent applications by Fu Xinping

Xinping Fu from Houston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250172561A1

Physics

PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS

#2 | 2025-05-22

US20250164490A1

Physics

PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS

#3 | 2024-05-09

US20240150787A1

Chemistry; metallurgy

ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITY

#4 | 2024-04-18

US20240123004A1

Human necessities

ONCOLYTIC VIRUS FOR SYSTEMIC DELIVERY AND ENHANCED ANTI-TUMOR ACTIVITIES

#5 | 2023-09-21

US20230295661A1

Chemistry; metallurgy

PERSISTENT HSV GENE DELIVERY SYSTEM

#6 | 2021-04-08

US20210102946A1

Physics

Probe for universal detection of circulating tumor cells

#7 | 2015-09-03

US20150246086A1

Human necessities

Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy

#8 | 2015-06-04

US20150150920A1

Human necessities

Mutant herpes simplex virus-2 for cancer therapy

#9 | 2014-12-18

US20140369977A1

Human necessities

Targeting Tumor Neovasculature with Modified Chimeric Antigen Receptors

#10 | 2012-11-29

US20120301506A1

Human necessities

Oncolytic Virus as an Inducer for Innate Antitumor Immunity

#11 | 2012-09-20

US20120237481A1

Human necessities

Incorporation of the B18R gene to enhance antitumor effect of virotherapy

#12 | 2012-04-26

US20120100109A1

Human necessities

Method for increasing the replication of oncolytic HSVs in highly resistant tumor cells using mTOR pathway and PI3K inhibitors

InventorID:

1006083 ⎘